Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
TXGthis company10x Genomics, Inc.	$63.06	-46.6×	2.56×	3.17×	439.61×	-115.9%	69.1%	-17.2%	-6.8%	-5.5%	-12.3%	6.4%	0.2×	-80.9×	0×	4.46×	0.0%	3	23.85	1	C-
AAgilent Technologies, Inc.	$178.69	31.89×	6.14×	5.96×	23.43×	-60.2%	52.4%	21.3%	18.8%	19.3%	12.6%	2.8%	0.5×	0.85×	13.21×	1.96×	0.7%	6	5.82	3	B+
BIOBio-Rad Laboratories, Inc.	$390.14	10.87×	1.11×	3.2×	7.65×	-146.4%	52.0%	10.5%	29.4%	10.2%	2.0%	4.5%	0.21×	0.83×	5.52×	5.62×	0.0%	7	3.65	3	B
ILMNIllumina, Inc.	$219.44	24.54×	7.65×	4.81×	15.09×	-124.1%	66.7%	19.9%	19.6%	31.2%	12.0%	4.5%	0.94×	0.78×	8.55×	2.08×	0.0%	7	7.4	3	B
LABStandard BioTools Inc.	$0.69	-6.4×	1.15×	5.72×	-4.68×	-325.1%	49.9%	-109.3%	-87.8%	-17.7%	-12.2%	-16.9%	0.07×	1.02×	-3,588.65×	4.19×	0.0%	3	-0.44	2	C+
RVTYRevvity, Inc.	$159.32	46.69×	1.52×	3.85×	17.75×	-25.0%	53.1%	12.5%	8.5%	3.3%	2.8%	4.6%	0.48×	3.39×	3.87×	1.68×	0.3%	8	3.34	3	B-
Peer median	—	24.54×	1.52×	4.81×	15.09×	-124.1%	52.4%	12.5%	18.8%	10.2%	2.8%	4.5%	0.48×	0.85×	5.52×	2.08×	0.0%	7	3.65	3	—